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Background: The interaction of platelet CLEC-2 with Podoplanin is critical for development of the lymphatics.
Results:CLEC-2 forms a central cluster upon engagementwith Podoplanin, which clusters Podoplanin. Clustering is dependent
on Syk and is critical for adhesion.
Conclusion: Clustering regulates the interaction of platelets with lymphatic endothelial cells.
Significance: These findings account for the similar lymphatic phenotype of CLEC-2- and Syk-deficient mice.
The interaction ofC-type lectin receptor 2 (CLEC-2) on plate-
lets with Podoplanin on lymphatic endothelial cells initiates
platelet signaling events that are necessary for prevention of
blood-lymph mixing during development. In the present study,
we show that CLEC-2 signaling via Src family and Syk tyrosine
kinases promotes platelet adhesion to primarymouse lymphatic
endothelial cells at low shear. Using supported lipid bilayers
containing mobile Podoplanin, we further show that activation
of Src and Syk in platelets promotes clustering of CLEC-2 and
Podoplanin. Clusters of CLEC-2-bound Podoplanin migrate
rapidly to the center of the platelet to form a single structure.
Fluorescence lifetime imaging demonstrates that molecules
within these clusters are within 10 nm of one another and that
the clusters are disrupted by inhibition of Src and Syk family
kinases. CLEC-2 clusters are also seen in platelets adhered to
immobilized Podoplanin using direct stochastic optical recon-
struction microscopy. These findings provide mechanistic
insight by which CLEC-2 signaling promotes adhesion to Podo-
planin and regulation of Podoplanin signaling, thereby contrib-
uting to lymphatic vasculature development.
The C-type lectin-like receptor CLEC-23 is a type II trans-
membrane protein that is highly expressed on the surface of
platelets and megakaryocytes and less so on dendritic cells (1,
2). Unlike classical immunoreceptor tyrosine-based activation
motif (ITAM)-containing receptors, which possess a tandem
YXXL sequence, CLEC-2 is characterized by a single YXXL
sequence, known as a hemITAM, in its cytosolic tail. Tyrosine
phosphorylation of the hemITAM sequence following ligand
engagement is mediated by the interplay between Src family
and Syk tyrosine kinases (3–5). Recruitment and stimulation of
Src family and Syk kinases lead to platelet activation involving
the adapter protein SLP-76 and effector enzyme phospholipase
C2 (1, 3, 6, 7).
The only established endogenous ligand for CLEC-2 is Podo-
planin. This sialomucin-like glycoprotein has a wide tissue dis-
tribution and is found at a high level in lung type I alveolar cells,
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kidney podocytes, choroid plexus epithelium, lymphatic endo-
thelial cells (LECs), and fibroblastic reticular cells within sec-
ondary lymphoid organs. Podoplanin is not found on vascular
endothelial cells. Podoplanin is up-regulated in a variety of
tumors and on macrophages following lipopolysaccharide
stimulation (8–10). Cells expressing Podoplanin or recombi-
nant forms of the Podoplanin extracellular domain have been
shown to induce platelet activation (6, 7, 9, 11).
Podoplanin has a single transmembrane region and a short
cytoplasmic tail of nine amino acids (12). Three basic residues
and a phosphorylated serine within the cytoplasmic tail confer
direct binding of the Podoplanin cytoplasmic tail to ezrin and
moesin, members of the ERM (ezrin, radixin, andmoesin) fam-
ily. ERM proteins provide a link between integral membrane
proteins and the actin cytoskeleton. Overexpression of Podo-
planin results in increased ERM protein phosphorylation (13,
14), and this interaction underlies many of the effects of Podo-
planin on the actin cytoskeleton. The small GTPase RhoA is
implicated in regulating the association of ERM proteins with
their membrane targets. Knockdown of Podoplanin in micro-
vascular LECs abrogates RhoA activation in association with a
reduction in cell migration and tube formation (15, 16). In can-
cer cell lines, overexpression of Podoplanin leads to RhoA acti-
vation, and this correlates with the acquisition of a migratory
phenotype and the onset of epithelial-mesenchymal transition
(13). Significantly, knockdown or clustering of Podoplanin has
been shown to prevent cell migration consistent with a model
inwhich the transmembrane protein regulates the cytoskeleton
through constitutive signaling (13, 17, 18).
Through an interactionwith Podoplanin, CLEC-2 is essential
formaintaining separation of blood and lymphatic vasculatures
and preventing hemorrhaging in the brain during development
(7, 11, 17, 19–23). Blood-lymphatic mixing and hemorrhaging
is present in mice with a megakaryocyte/platelet-specific dele-
tion of CLEC-2, suggesting a role for this lineage in develop-
ment (17). Megakaryocyte/platelet-specific deletion of the
CLEC-2 signaling proteins, Syk and SLP-76, also results in
blood-lymphatic mixing and brain hemorrhaging (17, 21, 24).
These observations indicate that the direct interaction of
CLEC-2 with Podoplanin and the initiation of platelet signaling
are critical for normal development. Consistentwith this, plate-
lets are activated upon binding to LECs as shown by imaging of
Ca2. Elevation of Ca2 was blocked in the presence of a Syk
inhibitor (25).
In this study, we have investigated the mechanism by which
platelets and primary LECs and Podoplanin-expressing cell
lines interact. We have monitored the dynamics of CLEC-2-
Podoplanin interactions and investigated the role of CLEC-2
signaling in the interaction using a planar lipid bilayer system
that maintains lateral mobility of recombinant Podoplanin.
Thismethod has been used to study the immunological synapse
formed by T, B, and natural killer cells (26). Using glass-sup-
ported planar lipid bilayers containing recombinant Podopla-
nin,we demonstrate thatCLEC-2-mediated signaling enhances
platelet adhesion by regulating formation of Podoplanin clus-
ters.We show that adhesion of platelets to primarymouse LECs
at low shear is regulated by Src family and Syk tyrosine kinases.
These findings provide a mechanism for the stable adhesion of
platelets to Podoplanin-expressing cells and also the regulation
of Podoplanin signaling, which likely contributes to the
requirement for CLEC-2 signaling in development of the lym-
phatic system.
EXPERIMENTAL PROCEDURES
Reagents and Antibodies—Monobiotinylation of mPDPN-Fc
and 17D9 was performed as previously described for the
monobiotinylation of antibodies (27). Alexa 488 and Dylight
595 labeling of monobiotinylated mPDPN-Fc was performed
by following the manufacturer’s instructions (Invitrogen and
Thermo Scientific). Phycoerythrin-conjugated anti-human Podo-
planin NZ-1–3 and rat IgG2a isotype control (eBioscience).
Quantum Simply Cellular anti-rat IgG microspheres (Bangs
Laboratories, Inc). Lotrafiban (GlaxoSmithKline), and dasat-
inib (LC Laboratories) were used. PRT-060318 was kindly
donated by Portola Pharmaceuticals. Antibodies against lym-
phatic endothelial cell markers Prox-1 and LYVE-1 were pur-
chased from Fitzgerald Industries and R&D Systems, respec-
tively. mCLEC-2 antibodies INU1 and 17D9 have been
previously described (28, 29). All other reagents were pur-
chased from Sigma-Aldrich.
Expression of mPDPN-Fc—The extracellular domain of
mouse Podoplanin was amplified from cDNA generated from a
C57BL/6 kidney with the primers mPodoHindFor (GATCAA-
GCTTATGTGGACCGTGCCAGTGTTG) and mPodoFcRev
(GATCGGATCCACTTACCTGTCAGGGTGACTACTGG-
CAAGCC). After digestion with HindIII and BamHI, the PCR
product was cloned into IgFc vector pcDNA3Ig to yield a con-
struct encoding the extracellular domain of Podoplanin fused at
the C terminus to the Fc region of human IgG1. For expression
and purification of the Podoplanin-Fc fusion protein, the
expression vector was transfected into 293T cells using the
polyethylenimine transfection method. The fusion protein was
purified by affinity chromatography using protein A-Sephar-
ose. mPDPN-Fc-containing fractions were dialyzed into PBS.
mPodoplanin Constructs—Full-length mouse Podoplanin was
cloned into pAcGFPN1 and pDsRedmonomerN1 (Clontech).
mCLEC-2GFPConstruct—Full-lengthmCLEC-2was cloned
into pAcGFPC1 to generate an N-terminal GFP fusion of
mCLEC-2. An 12-amino acid linker was added between the
GFP and mCLEC-2 to maintain function. Receptor function
was assessed using anNFAT luciferase reporter assay (30) (data
not shown).
Mouse Models—Generation and characterization of a condi-
tional SykR41A knock-in mouse (PF4-Cre sykR41Afl/fl) are
described elsewhere (64). PF4-Cre clec1bfl/fl and Lifeact-GFP
transgenic mice have been described previously (17, 31). The
mice were housed in accordance with institutional guidelines
approved by the United Kingdom Home Office.
Preparation of Mouse Platelets—Whole blood was drawn
from the inferior vena cava into acid citrate dextrose (1/9 v/v)
from CO2-asphyxiated mice following isofluorane anesthesia.
Washed mouse platelets were obtained as previously described
(32). Briefly, platelets were obtained by centrifugation using
prostaglandin I2 to prevent activation during the isolation pro-
cedure. Washed platelets were then resuspended in modified
HEPES Tyrode buffer (134 mM NaCl, 2.9 mM KCl, 12 mM
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NaHCO3, 0.34 mM NaH2PO4, 1 mM MgCl2, 5.5 mM glucose, 1
mM MgCl2, 20 mM HEPES, and 5 mM glucose, pH 7.3) at a
density of 2 107 platelets/ml.
Static Adhesion Assays—Acid-washed coverslips were incu-
bated with a 10 g/ml suspension of mPDPN-Fc overnight at
4 °C. Surfaceswere then blockedwith denaturedBSA (5mg/ml)
for 1 h at room temperature followed by subsequent washing
with PBS before use in spreading assays. Platelets (2 107/ml)
were allowed to adhere for 45 min at 37 °C. Nonadhered plate-
lets were removed by PBS washes before fixation with 10% for-
malin, neutral buffered, for 10 min at room temperature.
Cell Adhesion Assays—Cells were transfected with the indi-
cated constructs 48 h before the addition of platelets. Platelets
were allowed to adhere for 1 h at 37 °C. Nonadhered platelets
were removed by PBS washes prior to fixation with 10% forma-
lin, neutral buffered, for 10 min at room temperature.
Mouse Lymphatic Endothelial Cell Preparation—Primary
mouse dermal LECs were isolated from C57BL/6 P2-3 pups.
Briefly, the epidermis was removed from the dermis following
an overnight incubation at 4 °C with 2 mg/ml dispase (Invitro-
gen). The tissue was then digested using 2mg/ml collagenase A
while shaking at 37 °C for 30 min. A single cell suspension was
then added to 0.1% gelatin-coated tissue culture flasks in RPMI
medium supplementedwith 10% fetal calf serum, 1% penicillin/
streptomycin, and glutamine. Nonadhered cells were removed
after 3 h, and adhered cells were then cultured in freshly made
endothelial cell growth medium (EGM-2; Lonza). Following an
overnight incubation at 37 °C, adhered cells were dislodged
using Accutase (Sigma-Aldrich). LECs were isolated with anti-
LYVE-1 antibody-conjugated magnetic beads and grown in a
0.1% gelatin-coated tissue culture flask with supplemented
EGM-2. The cells were seeded into 8-well chamber culture
slides (BD Falcon) or Ibidi -slides VI 0.4 (Thistle Scientific)
until a confluent monolayer of LECs had formed.
Flow Adhesion Assays—Blood was drawn as previously
described into sodium-heparin (5 units/ml) and PPACK (40 M)
to prevent thrombin generation. Blood was perfused through
the Ibidi channels for 4 min at a shear rate of 50 s1 at 37 °C.
Nonadhered platelets were removed by a Tyrode’s buffer wash
prior to fixationwith 10% formalin, neutral buffered, for 10min
at room temperature. The integrity of the mouse LEC mono-
layer was confirmed with LYVE-1 staining, and platelets were
stained with an anti-IIb antibody.
Preparation of Planar Lipid Bilayers—Planar lipid bilayers
were generated as previously described (33). Liposomes con-
taining biotinylated lipids (cap-biotinyl-phosphatidylethano-
lamine) were mixed with 1,2-dioleoylphophatidylcholine lipo-
somes (Avanti Polar Lipids, Inc.). Liposomes were deposited on
a glass coverslip cleaned by piranha solution (a mixture of sul-
furic acid andhydrogenperoxide) assembled inBioptechs FCS2
chambers. Bilayers were blocked with PBS, 2% fatty acid-free
BSA (Sigma). Monobiotinylated mPDPN-Fc or monobiotiny-
lated mCLEC-2 antibody (17D9) was loaded into the bilayers
following a previous incubation with Alexa Fluor 405 strepta-
vidin. Bilayermobility was confirmed using fluorescence recov-
ery after photon bleaching. A cytometric method was used to
estimate the number of mPDPN-Fc molecules incorporated
into a bilayer. Bilayers containing Alexa 488-conjugated
mPDPN-Fc were reconstituted on glass beads and compared
with standard values obtained from microbeads with different
calibrated Alexa 488 fluorophores on their surface (Bangs Lab-
oratories, Inc). Beads were analyzed using a FACScalibur
cytometer (BD Bioscience).
Microscopy and Image Analysis—Platelets interacting with
LECswere imaged using an integrinIIb antibody. Platelet cov-
erage was determined by the integrin IIb threshold area using
ImageJ and presented as a percentage of total image area. Plate-
let adhesion and spreading morphology were imaged using
Ko¨hler illuminated Nomarski differential interference contrast
optics with a Zeiss 63 oil immersion 1.40 NA plan-apochro-
mat lens on a Zeiss Axiovert 200Mmicroscope. Digital images
were captured by aHamamatsuOrca 285 cooled digital camera
(Cairn Research, Kent, UK) using Slidebook 4.0 (Intelligent
Imaging Innovations, Inc., Denver, CO). The degree of platelet
adhesion and surface area of spread platelet were calculated
using ImageJ by outlining each individual platelet. The average
platelet surface area of at least 50 platelets was calculated for
each condition of each experimental replicate. Ten fields of
view per condition of each experimental replicate were used to
calculate the average number of platelets adhered per m2.
All cell incubation and live cell imaging were performed at
37 °C. The contact of platelets with the planar lipid bilayer was
visualized using total internal reflection fluorescence (TIRF)
microscopy. The sequences in supplemental Movies S1 and S2
are representative of at least three independent experiments
with at least 10 cells observed in each. Images were acquired
using a Nikon TIRF system on a Nikon Eclipse Ti inverted
microscope using illumination through the objective with a
CFL Plan Apo 60, 1.49 NATIRF objective and analyzed using
NIS Elements software and ImageJ. Interference reflection
microscopy (IRM) and confocal images were acquired using a
DM IRE2 Leica microscope using a 63 oil immersion objec-
tive. The average threshold area of 20 platelets was calculated
for each condition of each experimental replicate.
Analysis of Podoplanin Clustering by FRET-FLIM—Cluster-
ing of Podoplanin was analyzed by FRET using time-gated
FLIM, as described previously (34). In short, the fluorescence
lifetimes of the donor fluorophore (488 mPDPN-Fc) were
determined in the absence and presence of acceptor fluoro-
phore (594 mPDPN-Fc) and subsequently used to calculate the
FRET efficiency, defined as follows,
FRET Efficiency
D D/A
D
 100% (Eq. 1)
where  is the donor fluorophore lifetime in nanoseconds in the
absence (D) and presence (D/A) of the acceptor fluorophore.
To determine variation in FRET efficiency, the lifetimes of
three randomly chosen quadrants were quantified.
Statistical Analysis—Comparisons between groups were
analyzed by Student’s two-tailed paired t test with a significance
level of p  0.05. Where indicated, the data were analyzed by
analysis of variance test.
Stochastic Optic Reconstruction Microscopy—Wild type mouse
platelets were spread for 45 min on 10 g/ml Fc-Podoplanin-
coated coverslips. Platelets were fixed, permeabilized, and CLEC-
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2-labeled using 5 g/ml INU1 antibody. They were then second-
arily labeled using an Alexa 647-conjugated goat -rat antibody.
Samples were imaged in direct stochastic optical reconstruction
microscopy (dSTORM)mode using a 100 1.49NATIRF objec-
tive on aNikonN-STORMsystem consisting of a Ti-E standwith
Perfect Focus, Agilent MLC400 high power laser bed (647-nm
laser line) and Andor iXon Ultra DU-897U EMCCD camera. To
induce fluorophore blinking the samples were imaged in a PBS
buffer containing 100 mM mercaptoethylamine-HCl, 50 g/ml
glucose oxidase, and 1 g/ml catalase as detailed (35). 30,000
frames were captured using NIS Elements 4.2 with an exposure
time of 9.2 ms, gain 300, and conversion gain 3. dSTORM images
were reconstructed using the default settings in the Nikon
STORM analysis module v3.2. Samples were drift corrected and
rendered using Gaussian rendering. Cluster analysis was per-
formed with MATLAB using a custom made algorithm. Cluster
maps of the localized molecules were generated by evaluating the
number of localizations within a distance, 50 nm, of each point on
a 5-nm resolution grid across the region of interest. The cluster
level (L(50)) at each of these points, i, was calculated as follows,
Li50  An1 /	 (Eq. 2)
whereA is the area of the region of interest (in this case 3000
3000 nm), n is the total number of localizations within that area
and i is the number of localizations with a distance of 50 nm of
grid point i. This grid was then pseudocolored by L(50) level to
generate the cluster heat map. Edge effects were corrected by
processing a border of width (r) around each region. At least 20
platelets from three independent experiments were analyzed.
To generate Ripley’s K-function curves, the Excel plugin
SpPack was used (36). Here, the cluster level (L(r)), was calcu-
lated for each region of interest for a range of r as follows,
Lr   An2 
k  1
n 
j  1
n
kj /	 (Eq. 3)
where kj 1 is the distance between points k and j, is less than
r, and is otherwise 0. In this case, the completely spatially ran-
dom distribution has L(r) r for all r and therefore has L(r)
r  0. Therefore, clustered distributions have values of L(r) 
r 	 0. Border correction was performed by weighting the L(r)
calculation for molecules within distance r of the border. To
calculate 99% confidence interval for clustering, 100 completely
spatially random distributions were simulated per analyzed
region.
RESULTS
Platelet Signaling Enhances Platelet Adhesion to Primary
Mouse Lymphatic Endothelial Cells under Static and Flow
Conditions—To determine the role that platelet signaling plays
in the adhesion of mouse platelets to Podoplanin-expressing
cells, we investigated the interaction of platelets with primary
mouse dermal LECs. Prox-1 and LYVE-1 are used as a marker
for LECs. This combination was used to verify the purity of
mouse primary LEC preparations isolated from skin (data not
shown). Platelets, in the presence and absence of Src family and
Syk kinase inhibitors, were allowed to interact with a confluent
monolayer of primary mouse LECs for 60 min (Fig. 1A). Plate-
lets were identified with an integrin subunit IIb antibody, and
surface coverage was determined (Fig. 1B). Mouse platelets
adhere to mouse LECs in a CLEC-2-dependent manner,
because CLEC-2 deficient platelets do not adhere to primary
LECs (Fig. 1). The adhesion of platelets to mouse LECs was
decreased by over 70% in the presence of the selective tyrosine
kinase inhibitors PP2 (Src family) and PRT-060318 (Syk).
Although an effect of PP2 on the LECs cannot be excluded
because of the ubiquitous expression of Src family kinases, the
effect of the highly selective Syk inhibitor PRT-060318 (37) on
these cells is likely to be minimal because Syk has a hematopoi-
etic cell-specific expression. Lineage tracking has demon-
strated that Syk is not expressed in lymphatic or blood endo-
thelial cells inmice (38).We confirmed the absence of Syk from
mLECs by immunoblotting for Syk (data not shown). More-
over, the same concentration of PRT-060318 abolished platelet
Syk-dependent collagen signaling but not Src kinase-mediated
phosphorylation of the GPVI-FcR -chain complex,4 demon-
strating its specificity.
Given that the interaction between platelets and LECs are
expected to occur under conditions of venous flow, mouse
blood was perfused over a confluent monolayer of primary
mouse LECs at a wall shear rate of 50 s1 (Fig. 1C). To exclu-
sively investigate platelet-endothelial interactions, perfusion
was performed in the presence of theIIb
3 blocker lotrafiban.
Platelets were identifiedwith an integrin subunitIIb antibody.
A LYVE-1 antibody was used to ensure that the integrity of the
LEC monolayer was preserved in the presence of flow. Inhibi-
tion of platelet adhesion to primary LECs was seen under flow
conditions in the presence of the plasma available Src family
inhibitor dasatinib or Syk inhibitor PRT-060318 (Fig. 1D).
These results demonstrate a role for Syk and Src family kinases
in supporting adhesion to endogenous Podoplanin in mouse
primary LECs under static and flow conditions. To validate the
role of Syk inCLEC-2-mediated adhesion tomLECs in the pres-
ence of flow, we perfused blood from a novel knockin floxed
mouse in which arginine 41 in the SH2 domain of Syk has been
replaced with alanine (SykR41A). This mutation renders the
SH2 domain unable to bind to phosphorylated tyrosine (39).
As seen with whole blood treated with a Syk inhibitor, platelet
adhesion to a mLEC monolayer was reduced in platelets
expressing SykR41A (PF4-CreSykR41Afl/fl) when compared
with platelets expressing wild type Syk (SykR41Afl/fl) (Fig. 1E).
Immobilized Podoplanin Supports Platelet Adhesion and
Spreading through Src and Syk Kinases—To investigate the
interaction of platelets with Podoplanin in the absence of other
potential interacting proteins on LECs, we examined the inter-
action of platelets with immobilized Podoplanin by allowing
mouse platelets to adhere and spread on an immobilizedmono-
layer of mPDPN-Fc, a recombinant Fc fusion of the mouse
Podoplanin extracellular domain. After fixation, differential
interference contrast (DIC) microscopy was used to visualize
the extent of platelet spreading. Control platelets generate
4 C. E. Hughes, L. Navarro-Nun˜ez, and S. P. Watson, unpublished data.
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filopodia and lamellipodia over immobilizedmPDPN-Fc reach-
ing a size of 27.1 
 0.7 m2 (Fig. 2, A and B). This interaction
was mediated by CLEC-2, because CLEC-2-deficient platelets
displayed a similar level of adhesion as seen for wild type plate-
lets on BSA or an Fc-control protein (Fig. 2C). Inhibition of
CLEC-2 signaling by pretreating platelets with the Syk inhibitor
PRT-060318 or the Src family inhibitor PP2 prevented forma-
tion of lamellipodia and markedly reduced the spread area to
13.5
 1.4 and 11.3
 1.2m2, respectively.However, therewas
evidence of filopodia formation in the presence of these inhib-
itors (Fig. 2A). Strikingly, Syk or Src family kinase inhibition led
to a decrease of approximately 50% in the total number of plate-
lets adhered to immobilized Podoplanin, demonstrating a crit-
ical role for platelet activation in mediating stable adhesion
(Fig. 2, A and C).
To validate the role of Syk in Podoplanin-mediated platelet
spreading, we used platelets expressing SykR41A. As seen with
platelets treated with a Syk inhibitor, Podoplanin-mediated
platelet spreading was abolished in platelets expressing
SykR41A (PF4-CreSykR41Afl/fl) when compared with plate-
lets expressing wild type Syk (SykR41Afl/fl) (Fig. 2D). Plate-
lets expressing SykR41A also had a reduction of approxi-
mately 50% in adhesion to an immobilized layer of
mPDPN-Fc (Fig. 2E). These results demonstrate that CLEC-
2-mediated activation of Src and Syk tyrosine kinases is crit-
ical for spreading and is required for efficient adhesion to an
immobilized monolayer of Podoplanin. We have previously
reported that activation of Syk by CLEC-2 is dependent on
actin polymerization (6). Thus, it appears that CLEC-2 acti-
vation is regulated by actin-dependent feedback mecha-
nisms. Consistent with this, the interaction of platelets with
the immobilized Podoplanin is significantly reduced by dis-
ruption of the cytoskeleton (Fig. 2E).
Mobile Podoplanin Supports Platelet Adhesion and Spread-
ing through Src and Syk Kinases—The results in Fig. 1 demon-
strate a critical role for CLEC-2 signaling in supporting
adhesion to membrane-bound endogenous Podoplanin. To
investigate the molecular mechanisms governing the role of
CLEC-2, Src family and Syk kinases in platelet adhesion to
membrane Podoplanin, we modeled the situation using a pla-
nar lipid bilayer system. To achieve this, we used glass-sup-
ported lipid bilayers containing biotinylated lipids to which
monobiotinylated mPDPN-Fc was tethered via streptavidin
(Fig. 3A).
FIGURE 1. CLEC-2 signaling supports platelet adhesion to primary mouse lymphatic endothelial cells under static and flow conditions. A, CLEC-2-
deficient (PF4-Cre Clec1bfl/fl) or control (Clec1bfl/fl) platelets in the presence or absence of inhibitors to Src family (PP2, 20M) or Syk (PRT-060318, 5M) kinases
were incubated with a confluent monolayer of primarymouse LECs (DIC image) for 1 h at 37 °C. Platelets were identified using and anti-IIb antibody (green).
Scale bar, 20m. B, quantification of CLEC-2-deficient (PF4-CreClec1bfl/fl) or control (Clec1bfl/fl) platelet coverage in the presence or absence of inhibitors to Src
family (PP2, 20M) or Syk (PRT-060318, 5M) kinases. *, p 0.01 in analysis of variance. C, control blood in the presence or absence of inhibitors to Src family
(10 M dasatinib) or Syk (PRT-060318, 30 M) kinases was perfused over primary mouse LECs at a wall shear rate of 50 s1 at 37 °C. An arrow indicates the
direction of flow. LECs and platelets were identified using anti-LYVE-1 and anti-IIb antibodies, respectively. Integrin IIb antibody threshold (right panels).
Scale bar, 20 m. D, quantification of platelet adhesion to primary mouse LECs under flow conditions in the presence or absence of inhibitors to Src family
kinases (10Mdasatinib) or Syk kinase (PRT-060318, 30M). E, control (SykR41A fl/fl) or SykR41Aexpressing (PF4-CreSykR41Afl/fl)mousebloodwasperfusedover
primary mouse LECs at a wall shear rate of 50 s1 at 37 °C. An arrow indicates the direction of flow. LECs and platelets were identified using anti-LYVE-1 and
anti-IIb antibodies, respectively. Scale bar, 20 m. *, p 0.01 in analysis of variance.
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We sought to introduce Podoplanin into the supported lipid
bilayers at a level similar to that in Podoplanin-expressing cells.
The mean surface density of Podoplanin on HEK293T cells,
human dermal microvascular endothelial (HMEC-1) cells, and
squamouscell carcinoma (FaDu)cellswasdeterminedbycompar-
ing Podoplanin antibody-stained cells to calibration beads with
known antigen binding capacities (Table 1). Glass beads, coated
with mPDPN-Fc reconstituted supported lipid bilayers, were
compared with standard beads of known fluorophore number to
estimate the number of mPDPN-Fc molecules incorporated into
thebilayer.Thebilayerscontained48
10moleculesmPDPN-Fc/
m2.Allowing for the fact thatmPDPN-Fc contains two extracel-
lular domains of Podoplanin, this falls within the 5-fold range of
the density of Podoplanin on the above cell lines (Table 1).
Platelets were found to interact with the supported lipid
bilayers when mPDPN-Fc is tethered to the bilayer. Omission
FIGURE 2. Syk and Src family kinases support platelet adhesion to immobilized Podoplanin. A, washed platelets in the presence or absence of Src family
(PP2, 20 M) or Syk (PRT-060318, 5 M) kinase inhibitors were allowed to interact with mPDPN-Fc (10 g/ml)-coated glass coverslips for 45 min at 37 °C and
imaged using DICmicroscopy. Scale bar, 10m. B, quantification of platelet area when interactingwith immobilizedmPDPN-Fc in the presence or absence of
inhibitors to Src family (PP2, 20M) or Syk (PRT-060318, 5M) kinases. C, quantification of the number of adherent platelets interacting with BSA, a control Fc
protein, or immobilized mPDPN-Fc with or without Src family (PP2, 20 M) or Syk (PRT-060318, 5 M) kinase inhibitors. Quantification of the number of
CLEC-2-deficient (PF4-CreClec1bfl/fl) or control (Clec1bfl/fl) platelets interactingwithmPDPN-Fc.D, quantificationof control (SykR41A fl/fl) or SykR41Aexpressing
(PF4-CreSykR41Afl/fl) platelet area when interacting with immobilized mPDPN-Fc. E, quantification of the number of adhered SykR41A expressing (PF4-
CreSykR41Afl/fl) or control (SykR4A fl/fl) platelets with or without 10 M cytochalasin D interacting with immobilized mPDPN-Fc. Images and results are the
averages of three independent experiments
 S.D. *, p 0.05. Veh, vehicle.
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of the streptavidin, biotinylated lipids, or monobiotinylated
Podoplanin from the experimental setup results in very few
platelets interacting with the lipid bilayers (data not shown).
CLEC-2-deficient platelets did not interact with mPDPN-Fc-
containing supported lipid bilayers, demonstrating that the
interaction of platelets with the bilayer was mediated via the
interaction of CLEC-2 and Podoplanin (Fig. 3D). DIC micros-
copy was used to visualize the extent of platelet spreading on
mobile Podoplanin (Fig. 3B). Platelets underwent limited
spreading on the mPDPN-Fc containing supported lipid bilay-
ers (15.7 
 3.1 m2) in comparison with an immobilized sur-
face of mPDPN-Fc (Figs. 2B and 3C). Platelet anchorage medi-
ated by firm attachment to the immobilized surface of
mPDPN-Fc is likely to account for the difference in spreading.
Platelets treated with Src family and Syk kinase inhibitors have
a similar platelet area to control platelets when allowed to inter-
act with supported lipid bilayer-bound mPDPN-Fc (Fig. 3C). A
decrease in platelet adhesion was seen in the presence of Src
family and Syk kinase inhibitors on the supported lipid bilayers
similar to that observed on immobilized mPDPN-Fc (Fig. 3D).
These results therefore demonstrate that the role of Src family
and Syk kinases in supporting adhesion to Podoplanin is not
solely dependent on their role in mediating platelet spreading.
Inhibition of Src Family Kinases and Syk Results in Reduced
Contact Area between Platelets and Lipid Bilayer Supported
Podoplanin—Because the reduction in adhesion upon kinase
inhibition was not due to a decrease in platelet spreading, we
next considered the possibility that it was caused by a reduction
in the platelet-Podoplanin contact area. We used IRM to
address this and compared the results to the localization of
labeledmPDPN-Fc tethered to the supported lipid bilayers (Fig.
4). Destructive interference between the phase-shifted reflec-
tions from the glass to media interface and in the phase reflec-
tions from the media-cell interface results in dark areas when
the separation of the cell from the glass substrate is less than
half the wavelength of the incident light. Dark areas indicate
areas of close platelet-substrate contact.
Vehicle-treated platelets form a contact area similar to the
platelet area with evidence of dynamic lamellipodial extension
and collapse at the margins with a high degree of overall circu-
larity; in contrast, the fluorescent mPDPN-Fc forms a central
single bright cluster filling the center of the contact area result-
ing in an IRM/mPDPN-Fc ratio greater than 1 (Fig. 4,A andC).
Inhibition of Src family kinases with PP2 resulted in a reduction
in the overall close contact area with low circularity. Finger like
projections were entirely filled with labeledmPDPN-Fc, result-
ing in an IRM/mPDPN-Fc ratio of1,whereas the inhibition of
FIGURE 3. Syk and Src family kinases support platelet adhesion to mobile Podoplanin. A, schematic of the experimental system for mobile Podoplanin.
Platelets were allowed to interact with glass-supported planar lipid bilayers containing biotinylated lipids, to whichmonobiotinylated recombinant Podopla-
nin (mPDPN-Fc) was tethered via streptavidin. DOPC, dioleoylphosphocholine. B, washed platelets pretreated with or without Src family (PP2, 20 M) or Syk
(PRT-060318, 5 M) kinase inhibitors were allowed to interact with glass-supported planar lipid bilayers containing mobile mPDPN-Fc for 45 min at 37 °C and
imaged using DIC microscopy. Scale bar, 10 m. C, quantification of platelet area when interacting with mobile mPDPN-Fc with or without inhibitors to Src
family (PP2, 20M) or Syk (PRT-060318, 5M) kinases. The results are the averages of four independent experiments
 S.D.D, quantification of the number of
adherent platelets interactingwithmobilemPDPN-Fcwithorwithout inhibitors to Src family (PP2, 20M) or Syk (PRT-060318, 5M) kinases. Images and results
are the averages of three independent experiments
 S.D. **, p 0.01; ***, p 0.001. n.s., not significant; Veh, vehicle.
TABLE 1
Quantification of Podoplanin cell surface density
Cell type Podoplanin molecules/m2
HEK293T 270
 55
HMEC-1 253
 30
FaDu 501
 42
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Syk with PRT-060318 resulted in a highly circular contact
entirely filled with labeledmPDPN-Fc and an IRM/mPDPN-Fc
ratio of 1 (Fig. 4, A–C). These results demonstrate that the
role of Src and Syk kinases in supporting platelet adhesion to
the supported lipid bilayers is mediated through regulation of
the area of contact in distinct ways. The differential structures
seen in the presence of inhibitors of the two kinases is likely
because Src family kinases are upstream of Syk kinases, which
may have scaffolding roles in the absence of kinase activity, or
because Src kinases have additional substrates besides Syk
downstream of CLEC-2 activation.
Syk and Src Family Kinase InhibitionAlters PodoplaninClus-
ter Dynamics—We performed live cell imaging to investigate
the dynamics of platelet-mediated clustering of Podoplanin.
This was achieved by monitoring the interaction of Lifeact-
GFP-expressing platelets with Dylight 594-labeled Podoplanin
in a supported lipid bilayer using TIRF microscopy. Lifeact-
GFP is a specific probe for the actin cytoskeleton that enables
live cellmonitoring of cytoskeletal rearrangements (31) and can
be used to image the interplay between platelet cytoskeletal
rearrangements and Podoplanin localization.
As soon as the platelet contacts the membrane, Podoplanin
accumulation under the platelet can be detected. Initially small
clusters of Podoplanin form that rapidlymigrate with a centrip-
etal motion to form a bright central cluster (Fig. 5A, upper pan-
els, and supplemental Movie S1). The robust formation of a
central cluster occurs within 4 min (Fig. 5B).
The role of Syk in Podoplanin cluster dynamics was then
monitored in the presence of a Syk inhibitor, 5MPRT-060318
(Fig. 5A, lower panels, and supplemental Movie S1). Syk inhibi-
tion impeded the formation of the central Podoplanin cluster
and thereby increased the time to cluster formation to over 8
min (Fig. 5B). To validate the results using the Syk inhibitor, we
also monitored the interaction of platelets expressing SykR41A
with bilayers containing Dylight 594-labeled Podoplanin. As
seen with the Syk inhibitor, the dynamics of platelet-mediated
Podoplanin clustering were impeded in the presence of plate-
lets expressing SykR41A (Fig. 5C and supplemental Movie S2).
When compared with control platelets, there was a delay in the
formation of a central Podoplanin structure, which was similar
to platelets treatedwith the Syk inhibitor PRT-060318 (Fig. 5B).
These data suggest that the clustering of Podoplanin is depen-
dent on the binding of Syk to phosphotyrosine and on its kinase
activity.
We further investigated whether platelet-mediated forma-
tion of Podoplanin clusters was dependent on Src family
kinases using the Src family kinase inhibitor, PP2. In the pres-
ence of 20 M PP2, platelets formed numerous Podoplanin
clusters, but these clusters rarely coalesced to form a large cen-
tral structure within 45 min, as seen in control platelets and in
platelets treated with the Syk inhibitor PRT-060318 (Fig. 6).
Thus, the defect in the formation of a large central structure in
the absence of Src family kinase activity is more severe than the
clustering defect in the absence of Syk activity. This is consis-
FIGURE4.SykandSrc familykinase inhibitiondecreasesplatelet-bilayer interactions.A, platelets treatedwithvehicle, Syk (PRT-060318, 5M)or Src family
(PP220M) kinase inhibitorswere allowed to interactwithglass-supported lipidbilayers containingDylight 594-labeledmPDPN-Fc for 45minat 37 °C. IRMand
fluorescent images of the platelet/bilayer interface. Top panels, IRM; bottom panels, confocal images of Dylight 594-labeled mPDPN-Fc. B, example platelet
contact area shownas theoriginal unthresholded image (left panels) or after thresholdingandbinarization (right panels). Quantificationof close surface contact
areas of platelets interacting with mobile Podoplanin is shown. C, the ratio of the IRM threshold area to mPDPN-Fc area. The results are the averages of three
separate experiments
 S.D. *, p 0.05. Veh, vehicle.
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tent with Syk contributing to central clustering independent of
its catalytic activity or phosphotyrosine binding of its N-termi-
nal SH2 domain and with Src family kinase activity being nec-
essary for Syk to have this role.
Syk or Src Family Kinase Inhibition Decreases Tight Podopla-
nin Clustering—The above results show that the inhibition of
the tyrosine kinases downstream of CLEC-2 results in changes
in Podoplanin cluster formation by platelets. Although TIRF
imaging permits us to visualize cluster formation, it does not
have sufficient resolution to allow us to determine the proxim-
ity of Podoplanin molecules to one another. To determine
whether platelets cluster Podoplaninmoleculeswithin 10nmof
one another, we used FLIM to detect FRET (FRET-FLIM)
between Podoplanin molecules in the planar bilayer.
To enable FRET-FLIMmeasurements, mPDPN-Fc was con-
jugated to Alexa Fluor 488 (donor: 488 mPDPN-Fc) or Dylight
FIGURE 5. Role of Syk kinase in platelet-mediated Podoplanin cluster dynamics. A, TIRFM time course of Lifeact-GFP-expressing platelets interactingwith
planar lipid bilayer containing Dylight 594-labeledmPDPN-Fc. The top panels show control Lifeact-GFP-expressing platelets. The bottom panels show Lifeact-
GFPplatelets in the presence of a Syk kinase inhibitor (PRT-060318, 5M; see supplementalMovie S1). B, quantification of the time taken to forma single stable
central structure from the first point of contact. The results are the averages of three separate experiments
 S.D. *, p 0.01. C, DIC time course of control
(sykR41Afl/fl;upperpanels) or SykR41Aexpressing (PR4-CresykR41Afl/fl; lowerpanels) platelets interactingwithplanar lipidbilayer containingDylight594-labeled
mPDPN-Fc (see supplemental Movie S2). Time is relative to the first detected contact point. Scale bars, 2 m.
FIGURE 6. Src family kinase inhibition blocks Podoplanin cluster dynamics. A, TIRFM images of Lifeact-GFP-expressing platelets interacting with planar
lipid bilayer containing Dylight 594-labeled mPDPN-Fc for 45 min at 37 °C. Lifeact-GFP-expressing platelets were pretreated with Src family kinase inhibitor
(PP2, 20M) or a Syk inhibitor (PRT-060318, 5m). Scale bar, 10m. B, quantification of the clustermorphology in the presence and absence of Src family (PP2,
20M) or a Syk (PRT-060318, 5m) kinase inhibitors at 45min. Platelets were identified as having a single or multiple Podoplanin clusters. Images and results
are the averages of three independent experiments
 S.D.
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594 (acceptor: 594mPDPN-Fc). Platelets were allowed to inter-
actwith bilayers containing 488mPDPN-Fc or equivalent levels
of donor 488 mPDPN-Fc and acceptor 594 mPDPN-Fc for 45
min. Samples were fixed, and the average lifetime of 488
mPDPN-Fc was determined in the absence and presence of the
acceptor 594 mPDPN-Fc for platelets incubated with vehicle,
Syk inhibitor, PRT-060318, or Src family kinase inhibitor, PP2.
Fluorescence lifetimes were used to calculate the FRET effi-
ciency. In the presence of vehicle, platelets showed a decrease in
donor fluorescence lifetime, resulting in a FRET efficiency of
10
 2%. This indicates that the distance of Podoplanin mole-
cules was within 10 nmof one another (Fig. 7) and that platelets
promote the formation of tight Podoplanin clusters. Inhibition
of Syk andSrc family kinases results in a loss of FRET, indicating
that the average distance betweenPodoplaninmoleculeswithin
the bilayer was greater than 10 nm.
Platelets Cluster Podoplanin in HEK293T Cells—Thus far,
our results demonstrate that platelets are able to cluster Podo-
planin contained within a supported lipid bilayer. To examine
whether platelets are able to cluster Podoplanin on an intact cell
surface, we analyzed the interaction of platelets with HEK293T
cells overexpressing a C-terminal green fluorescent protein
fromAequorea coerulescens (AcGFP) fusion ofmouse Podopla-
nin (mPodoplanin). Following the interaction of platelets with
theAcGFPmPodoplanin-expressingHEK293T cells for 45min,
the cells were fixed, and the platelets were identified using an
antibody against the integrin subunit IIb. Despite the fact that
HEK293T cells express significant levels of endogenous human
Podoplanin, we found that very few mouse platelets interacted
with control cells expressing GFP alone (data not shown). In
contrast, HEK293T cells expressingmouse Podoplanin support
mouse platelet adhesion. The platelets interacting solely with
the AcGFPmPodoplanin-expressing HEK293T cells show a
reduced level of spreading when compared with platelets that
interact with both the cell and the coverslip (Fig. 8A). Interest-
ingly, confocal microscopy revealed a local accumulation of
Podoplanin below an attached platelet, which is occurring at
the interface between individual platelets and AcGFPmPodo-
planin-expressing cells (Fig. 8, A and B).
To assess clustering more quantitatively, we performed
FRET-FLIM on cells expressing either AcGFPmPodoplanin or
equivalent amounts of AcGFPmPodoplanin and DsRedmono-
mer-mPodoplanin (Fig. 9A). Platelets were allowed to interact
with cells expressing either AcGFPmPodoplanin or cells
expressing equivalent levels of AcGFPmPodoplanin and
DsRedmonomer-mPodoplanin for 1 h. Samples were fixed, and
the average lifetime of AcGFPmPodoplanin was determined in
the absence and presence of the acceptor DsRedmPodoplanin
for cells incubatedwith platelets treatedwith vehicle, Syk inhib-
itor, PRT-060318, or Src family kinase inhibitor, PP2. Fluores-
cence lifetimes were subsequently used to calculate the FRET
efficiency (Fig. 9B).
FIGURE 7. Syk and Src family kinase inhibition decreases Podoplanin clustering. A, platelets interacting with planar lipid bilayer containing Alexa 488-
labeledmPDPN-Fc or equivalent amounts of Alexa 488-labeledmPDPN-Fc andDylight 594-labeledmPDPN-Fc for 45min at 37 °C. Fluorescence lifetimes of the
donor fluorophore (mPDPN-Fc-488) were determined in the absence and presence of acceptor fluorophore (mPDPN-Fc-594). The fluorescence lifetimes in
nanoseconds (ns) are shownas false color images. Scale bar, 2m.B, FRET-FLIManalysis ofmPDPN-Fc containingbilayers incubatedwithplatelets treatedwith
orwithout inhibitors to Src family (PP2, 20M) or Syk (PRT-060318, 5M) kinases. Images and results are the averages of three independent experiments
 S.D.
Veh, vehicle.
FIGURE8.Podoplanin is recruitedat theplatelet-cell interface.A, HEK293T
cells expressing GFPmPodoplanin were analyzed in the presence of platelets
by confocal microscopy. Maximum intensity projection of GFPmPodoplanin
HEK293T cells (left panel) and platelets stained with an anti-IIb antibody
(middle panel). Themerged images are shown in the right panel (GFPmPodo-
planin, green; anti-IIb, blue). Clusters of GFPmPodoplanin associated with a
platelet are indicated by closed white arrowheads in the GFPmPodoplanin
image and superimposedon themerge image. Platelets only interactingwith
the GFPmPodoplanin HEK293T cell are indicated by open arrowheads. Plate-
lets interacting with both the GFPmPodoplanin HEK293T cell and the cover-
slip are indicated by red arrowheads. Scale bar, 10 m. B, confocal image of
GFPmPodoplanin (left panel) and anti-IIb antibody (middle panel). The
merged images are shown in the right panel (GFPmPodoplanin, green; anti-
IIb, Blue). xz and yz projections display a cross-section of a cell-platelet inter-
action. TheaccumulationofGFPmPodoplaninbetween thecell and theplate-
let is indicated by an open arrowhead in the xz and yz views. Scale bar, 2 m.
Images are representative of three independent experiments.
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In the absence of platelets, no FRET was observed (Fig. 9B).
Cells incubatedwith platelets in the presence of vehicle showed
a decrease in fluorescence lifetime, resulting in a FRET effi-
ciency of 13 
 2%. This indicates that the distance between
Podoplaninmolecules was within 10 nm, suggesting that plate-
lets can initiate the formation of tight clusters of Podoplanin in
cells. Inhibition of Syk and Src family kinases results in a loss of
FRET. These results agree with those on the interaction of
platelets with Podoplanin in an artificial bilayer and thereby
demonstrate a critical role for CLEC-2 signaling in supporting
adhesion to Podoplanin on a cell surface.
CLEC-2 Forms ClustersWhen Exposed to a CLEC-2 Ligand—
We infer that CLEC-2 forms clusters by investigating the
distribution of its ligand Podoplanin. To investigate the distri-
bution of CLEC-2 directly, mouse platelets were spread on
recombinant Podoplanin. The actin cytoskeleton was stained
with Alexa 488-phalloidin, and CLEC-2 was stained with Alexa
647-anti-mCLEC-2 antibody (INU1). TIRF imaging demon-
strates that CLEC-2 forms large clusters when platelets interact
with Podoplanin (Fig. 10A). To further resolve the spatial dis-
tribution of CLEC-2, we used dSTORM. This super resolution
method is able to resolve proteins with an20-nm spatial res-
olution (Fig 10B). To analyze the distribution of CLEC-2 mol-
ecules, we used amodified quantitative cluster mapping, which
has previously been used to analyze the distribution of proteins
molecules using dSTORM data (40). Molecules that display an
increased cluster distribution are presented as a cluster heat
map with “hot” colors identifying highly clustered molecules.
(Fig. 10B). The analysis demonstrates that the large cluster
observed using TIRFM is composed of smaller nanoscale clus-
ters. To assess the degree of clustering, we analyzed the distri-
bution of CLEC-2 by Ripley’s K function (Fig. 10B). Ripley’s
K-function analysis of the molecules in regions 1 and 2 reports
a significant increase in the degree of clustering relative to a
random distribution (indicated by the 99% confidence inter-
vals). Overall, we show that CLEC-2 is highly clustered when
platelets interact with recombinant Podoplanin.
To investigate both the spatial and temporal distribution of
CLEC-2, we generated an N-terminal GFP fusion of mouse
CLEC-2, which maintained receptor function when expressed
in a DT40 chicken B cell line (data not shown). Cells expressing
mCLEC-2-GFP were allowed to interact with a supported lipid
bilayer containing an activating antibody to CLEC-2 (17D9)
and imaged using TIRF microscopy. Following ligand engage-
ment, macroclusters of CLEC-2 migrate in a directed manner
toward the center of the cell (Fig. 10C and supplemental Movie
S3). This is comparable with the distribution of Podoplanin in a
supported lipid bilayer by platelets.
DISCUSSION
In this study, we have shown that CLEC-2 on platelets
induces the dynamic formation of tight clusters of its ligand
Podoplanin in amechanism that is dependent on Src family and
Syk kinase activity. Moreover, we demonstrate that the cluster-
ing mechanism greatly enhanced platelet adhesion to Podopla-
nin. In the presence of inhibitors of these kinases, Podoplanin
molecules are no longer tightly clustered because FRET effi-
ciency between donor-labeled and acceptor-labeled Podopla-
nin molecules is negligible. The individual binding affinity of
Podoplanin for CLEC-2 is low for an interaction that can sup-
port cell adhesion (Kd  24 M) (11). We hypothesize that
Podoplanin clustering by platelets leads to an increase in avid-
ity, which augments cell adhesion. The increase in avidity is
dependent on Src family and Syk kinase activation in platelets
and is likely mediated by centralization of CLEC-2 receptors
into a cluster, thereby also clustering Podoplanin, as demon-
strated in the supported lipid bilayer model.
Many single spanning membrane receptors do not function
as individual signaling units but instead associate in multimo-
FIGURE 9. CLEC-2 signaling leads to Podoplanin clustering in a cell mem-
brane. A, platelets were allowed to interact with cells expressing either
AcGFPmPodoplaninor cells expressingequivalent levels ofAcGFPmPodopla-
nin and DsRedmonomer-mPodoplanin for 1 h. Samples were fixed, and the
average lifetime of AcGFPmPodoplanin was determined in the absence and
presence of the acceptor DsRedmPodoplanin for cells incubated with plate-
lets treated with vehicle, Syk (PRT-060318, 5 M), or Src family (PP2 20 M)
kinase inhibitors. The fluorescence lifetimes innanoseconds (ns) are shownas
false color images. Scale bar, 10 m. B, FRET-FLIM analysis of cells expressing
AcGFPmPodoplanin incubated with platelets incubated with or without Syk
(PRT-060318, 5 M) or Src family (PP2 20 M) kinase inhibitors. Images and
results are the averages of three separate experiments
 S.D. *, p 0.01. Veh,
vehicle.
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lecular complexes. Formation of submicron clusters to initiate
signaling followed by consolidation in a larger central cluster
(macrocluster) is characteristic of ITAM/hemITAM contain-
ing immunoreceptors. The formation of a large central cluster
on this scale enhances the intracellular signal and has the
advantage of restricting the diffusion of molecules at the mem-
brane, such as the exclusion of membrane associated negative
regulators like CD45 (41, 42). Larger scale clustering can also be
associated with signal termination (43), maintenance (44), or
enhancement (45) in different systems. There is now consider-
able evidence to indicate that the size and spatial distribution of
signaling assemblies are highly regulated. Receptor redistribu-
tion can result in dynamic regulation of signaling from its initi-
ation to down-regulation. In the present study, we show that
CLEC-2-mediated signaling by Src family and Syk kinases plays
a key role in the formation of large Podoplanin (macro)clusters
in a Podoplanin-containing supported lipid bilayer and in a cell
membrane.
The stoichiometry of Podoplanin and CLEC-2 has been
reported to be one molecule of Podoplanin per CLEC-2 dimer
(46). Thus, dimerization of CLEC-2 in the absence of higher
order clustering is not expected to bring Podoplaninmonomers
within 10 nm of each other. Therefore, the potential require-
ment of Src and Syk kinase activity and Syk SH2 function to
formCLEC-2dimers is not sufficient to account for the induced
Podoplanin proximity as measured by FLIM and must reflect
higher order clustering. At the same time, the formation of a
central, albeit enlarged cluster is not sufficient to induce the
molecular scale Podoplanin clustering because Syk inhibition
and the Syk SH2 mutant eventually form a central cluster but
FIGURE 10. CLEC-2 can form clusters that, following ligand engagement,migrate in a directedmanner toward the center of the cell. A, washedmouse
plateletswere allowed to interactwithmPDPN-Fc (10g/ml)-coatedglass dishes for 45min at 37 °C. TIRFM imageof Alexa 488-phalloidin (left panel) andAlexa
647-anti-CLEC-2 (INU1) (middle panel). Themerged images are shown in the right panel (actin, green; mCLEC-2, red). Two regions of interest are highlighted, R1
and R2. Scale bar, 5m. B, TIRFM images of Alexa 647-anti-mCLEC-2 in the boxed regions from Fig. 10A (R1 and R2; left panels). dSTORM images of regions 1 and
2 (middle panels). Quantitative cluster mapping of the dSTORM images of regions 1 and 2 (right panels). Scale bar, 1 m. Ripley’s K-function analysis of the
molecules in regions 1 and 2; L(r)  r reports the degree of clustering relative to a random distribution (indicated by the lower and upper 99% confidence
intervals (CI) (red and green lines)), and r is the radial scale. C, TIRFM time course of a mCLEC-2-AcGFP-expressing DT40 chicken B cell interacting with a planar
lipid bilayer containing an CLEC-2-activating antibody (17D9) (see supplemental Movie S3). The bright field image shows the location of the cell. Scale bar, 2
m. Images are representative of three independent experiments.
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still lack the FRET signal indicative of bringing Podoplanin
monomers within 10 nm of each other.
The use of the supported lipid bilayer system revealed an
unexpected difference between the roles of Src family kinase
and Syk activity in cluster transport. Src inhibition resulted in a
more severe phenotype in which central clustering was inhib-
ited, whereas Syk inhibition resulted in impeded central clus-
tering. This resultmay reflect the potential for Syk to act as a Src
family kinase-dependent scaffold protein linking CLEC-2 clus-
ters to a cell-efficient centralization process or the possible acti-
vation of additional substrates by the Src kinase. A scaffolding
role for Syk family kinases has been proposed previously based
on binding of adapters to the interdomain phosphotyrosines,
which are phosphorylated in part by Src family kinases (47).
The present results are similar to the formation of the immu-
nological synapse that underlies signaling by the ITAM con-
taining T and B cell receptors (33, 48, 49). However, a notable
difference is the reduced dependence of ITAMreceptors on Src
family kinases in mediating clustering (49–52), which may
reflect a differential role of the ITAM and hemITAM signaling
units. In this context, Src and Syk family kinase-mediated for-
mation of the CLEC-2 dimer may be a necessary step to higher
order clustering of the ligand, whereas this is not the case for an
ITAM receptor.
The molecular basis of the requirement for platelet signaling
during lymphatic development is not known, although it does
not appear to depend on integrin activation or dense/-granule
secretion (17, 53, 54). Interestingly, we and others have shown
that addition of platelets to LECs leads to a decrease in endo-
thelial cell migration in vitro and that this is mirrored by the
clustering of Podoplanin by cross-linking antibodies or recom-
binant CLEC-2 (17, 18). A similar decrease in migration is seen
on antibody cross-linking of Podoplanin in osteosarcoma cells
(55). There is considerable evidence of a role for Podoplanin in
regulating cell migration. Up-regulation and knockdown of
Podoplanin has been reported to increase and decrease cell
migration, respectively (13, 16). These ligand-independent
effects may reflect constitutive signaling by Podoplanin. Thus,
inhibition of Podoplanin-regulatedmigration as a consequence
of interaction with CLEC-2- and Syk-dependent platelet acti-
vation provides evidence for an attractivemodel to explain how
platelet adhesion serves to halt migration of lymphatic vessels
upon contact with blood endothelial cells and thus prevent
joining of the two vasculatures during embryonic development.
This model is particularly attractive given the recent demon-
strations using ultramicroscopy that LECs migrate away from
the cardinal vein as single cells and only later on express Podo-
planin and join together to form lymphatic sacs and lymphatic
vessels (56). The inhibition of migration by platelets when in
contact with blood endothelial cells would prevent joining of
the two vasculatures.
Our results also raise the possibility that stable adhesion
between platelets and LECs contributes to the prevention of
blood-lymphatic mixing. Podoplanin clustering by CLEC-2-
mediated signaling in vivo is likely to contribute to the binding
of platelets to LECs. Additionally we have shown that CLEC-2
signaling influences the degree of Podoplanin clustering on the
LEC surface. We therefore speculate that, in a similar manner
to the effect that cross-linking of Podoplanin by specific anti-
bodies or recombinant CLEC-2 has on LEC migration (17, 18),
CLEC-2-mediated signaling regulates cross-linking of Podo-
planin molecules and thereby influences the motility of LECs
and thus halts migration upon contact with blood endothelial
cells. Podoplanin depletion causes Cdc42 activation and RhoA
inhibition, resulting in a decrease in lung microvascular endo-
thelial cell migration (16). It may be that formation of tight
FIGURE 11.Model summary of CLEC-2-mediated clustering of Podoplanin.We propose that the binding of CLEC-2 to Podoplanin enhances the adhesion
of platelets to lymphatic endothelial cells through CLEC-2-mediated receptor clustering involving the kinase Syk. We hypothesize that this would in turn lead
to clustering of Podoplanin and functional effects in the LECs by modulation of Podoplanin signaling though ERM proteins and regulation of the actin
cytoskeleton.
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clusters of Podoplanin initiated by platelet CLEC-2-mediated
signaling can regulate the activity of small GTPases, which
leads to inhibition of LEC migration.
Our results have implications for other physiologically rele-
vant interactions between platelet CLEC-2- and Podoplanin-
expressing cells. It has been recently reported that CLEC-2
plays a role in the prevention of inflammation-induced hemor-
rhage (57). Additionally, Podoplanin expressed on fibroblastic
reticular cells surrounding high endothelial venules acts as an
activating ligand for platelet CLEC-2 to release sphingosine
1-phosphate, which mediates up-regulation of VE-cadherin on
the endothelial cells, thus preventing leakage of blood into the
lymph node (58). Podoplanin up-regulated in metastatic
tumors has been proposed to promote CLEC-2 platelet activa-
tion and aggregation. The interaction between CLEC-2 and
Podoplanin has been associated with tumor cell arrest and
extravasation (7, 59–61). Platelet-mediated clustering of Podo-
planin may play a role in these processes by maintaining stable
adhesion as well as by regulating the level of platelet activation
and through inhibition of Podoplanin signaling.
CLEC-2 is also expressed on other hematopoietic lineages,
including dendritic cells (1, 2). Our findings therefore have
implications for the interaction of other CLEC-2-expressing
cells with Podoplanin. One such example is the role of CLEC-2
in regulating the migration of dendritic cells to lymph nodes
(62).
Our study has taken full advantage of the supported planar
bilayer model to advance the understanding of platelet
hemITAM signaling in maintaining adhesion. To our knowl-
edge, this is the first time this model system has been used to
providemechanistic insight into platelet and hemITAMsignal-
ing. Our findings were supported by the use of cells expressing
GFPmPodoplanin in which an accumulation of Podoplanin can
be found at the interface between a platelet and a cell. We pro-
pose that the binding of CLEC-2 to Podoplanin enhances the
adhesion of platelets to LECs throughCLEC-2-mediated recep-
tor clustering. We hypothesize that this would in turn lead to
clustering of Podoplanin and functional effects in the LECs by
down-regulation of Podoplanin signaling though ERMproteins
and the small GTPases Cdc42 and RhoA (see the model in Fig.
11). These observations are likely to contribute to the biology of
CLEC-2 and Podoplanin, including their role in prevention of
blood-lymphatic mixing during development that has recently
been proposed to occur at sites of low shear where the lymph is
returned to the bloodstream in the thoracic duct (63), as well as
through formation of blood-lymphatic contacts (18, 24, 38).
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